-
Body Mass Index at 11-13 Weeks' Gestation and Pregnancy Complications.
Syngelaki A, Bredaki FE, Vaikousi E, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2011;30:250-65. -
Maternal serum 25-hydroxyvitamin D levels at 11(+0) -13(+6) weeks in pregnant women with diabetes mellitus and in those with macrosomic neonates.
Savvidou M, Akolekar R, Samaha R, Masconi A, Nicolaides Kh.
BJOG 2011;118:951-5. -
Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy.
Plasencia W, Garcia R, Pereira S, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;30:108-15. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks.
Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH.
Prenat Diagn 2011;31:135-41. -
First-trimester circulating 25-hydroxyvitamin d levels and development of gestational diabetes mellitus.
Makgoba M, Nelson SM, Savvidou M, Messow CM, Nicolaides K, Sattar N.
Diabetes Care 2011;34:1091-3. -
Maternal serum visfatin at 11-13 Weeks of gestation in gestational diabetes mellitus.
Ferreira AF, Rezende JC, Vaikousi E, Akolekar R, Nicolaides KH.
Clin Chem 2011;57:609-13. -
Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women.
Bombard AT, Akolekar R, Farkas DH, Vanagtmael AL, Aquino F, Oeth P, Nicolaides KH.
Prenat Diagn 2011;31:802-8. -
Fetal RHD Genotyping in Maternal Plasma at 11-13 Weeks of Gestation.
Akolekar R, Finning K, Kuppusamy R, Daniels G, Nicolaides KH.
Fetal Diagn Ther 2011;29:301-6. -
Maternal arterial stiffness in pregnancies complicated by gestational and type 2 diabetes mellitus.
Savvidou MD, Anderson JM, Kaihura C, Nicolaides KH.
Am J Obstet Gynecol 2010;203:274. -
First trimester prediction of gestational diabetes: examining the potential of combining maternal characteristics and laboratory measures.
Savvidou M, Nelson SM, Makgoba M, Messow CM, Sattar N, Nicolaides K.
Diabetes 2010;59:3017-22. -
Maternal arterial stiffness in pregnancies affected by Type 1 diabetes mellitus.
Anderson JM, Savvidou MD, Kaihura C, McEniery CM, Nicolaides KH.
Diabet Med 2009;26:1135-40. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1550-6. -
Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity.
Scheier M, Hernandez-Andrade E, Carmo A, Dezerega V, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:432-6. -
Maternal serum level of placental growth factor in diabetic pregnancies.
Ong CY, Lao TT, Spencer K, Nicolaides KH.
J Reprod Med 2004;49:477-80. -
Predicting the severity of fetal anemia using time-domain measurement of volume flow in the fetal aorta.
Harrington K, Fayyad A, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:437-41. -
Fetal and embryonic hemoglobins in erythroblasts from fetal blood and fetal cells enriched from maternal blood in pregnancies complicated by maternal diabetes mellitus.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
J Matern Fetal Neonatal Med 2004;15:109-14. -
Severe hemolytic disease of the fetus following in vitro fertilization with anonymously donated oocytes.
Patel RK, Nicolaides K, Mijovic A.
Transfusion 2003;43:119-20.